Your browser doesn't support javascript.
loading
Deep learning pathological microscopic features in endemic nasopharyngeal cancer: Prognostic value and protentional role for individual induction chemotherapy.
Liu, Kuiyuan; Xia, Weixiong; Qiang, Mengyun; Chen, Xi; Liu, Jia; Guo, Xiang; Lv, Xing.
Afiliación
  • Liu K; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Xia W; Department of nasopharyngeal carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China.
  • Qiang M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Chen X; Department of nasopharyngeal carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China.
  • Liu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Guo X; Department of nasopharyngeal carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China.
  • Lv X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
Cancer Med ; 9(4): 1298-1306, 2020 02.
Article en En | MEDLINE | ID: mdl-31860791
ABSTRACT

BACKGROUND:

To explore the prognostic value and the role for treatment decision of pathological microscopic features in patients with nasopharyngeal carcinoma (NPC) using the method of deep learning.

METHODS:

The pathological microscopic features were extracted using the software QuPath (version 0.1.3. Queen's University) in the training cohort (Guangzhou training cohort, n = 843). We used the neural network DeepSurv to analyze the pathological microscopic features (DSPMF) and then classified patients into high-risk and low-risk groups through the time-dependent receiver operating characteristic (ROC). The prognosis accuracy of the pathological feature was validated in a validation cohort (n = 212). The primary endpoint was progression-free survival (PFS).

RESULTS:

We found 429 pathological microscopic features in the H&E image. Patients with high-risk scores in the training cohort had shorter 5-year PFS (HR 10.03, 6.06-16.61; P < .0001). The DSPMF (C-index 0.723) had the higher C-index than the EBV DNA (C-index 0.612) copies and the N stage (C-index 0.593). Furthermore, induction chemotherapy (ICT) plus concomitant chemoradiotherapy (CCRT) had better 5-year PFS to those received CCRT (P < .0001) in the high-risk group.

CONCLUSION:

The DSPMF is a reliable prognostic tool for survival risk in patients with NPC and might be able to guide the treatment decision.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Procesamiento de Imagen Asistido por Computador / Nasofaringe / Neoplasias Nasofaríngeas / Quimioradioterapia / Aprendizaje Profundo Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Procesamiento de Imagen Asistido por Computador / Nasofaringe / Neoplasias Nasofaríngeas / Quimioradioterapia / Aprendizaje Profundo Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: China
...